ImpediMed and Metagenics Announce Agreement

ImpediMed Ltd, a pioneer in the medical applications of bioimpedance technology and Metagenics, Inc., a global leader in science-based nutraceutical products, medical foods, and therapeutic lifestyle change programs, today announced an agreement to distribute ImpediMed technology in the United States and Canada. Metagenics’ Australian affiliate, Health World, Ltd, has been a long-standing customer of the Brisbane-based medical device manufacturer.

“We’ve seen the synergies of combining ImpediMed’s products for assessing fat and fluid status with our own research-based health and wellness products and programs, which we market to healthcare professionals,” said Mike Katke, VP of Medical Marketing for San Clemente, California-based Metagenics. “Their scientifically-grounded approach and the reliability and portability of their technology made offering ImpediMed to our customers a simple decision.”

ImpediMed CEO Greg Brown said, “Metagenics has been an outstanding Australian partner using ImpediMed’s body composition analysis devices for several years. This expanded relationship makes sense in light of our mutual focus on addressing wellness and healthier life styles.”

About Metagenics, Inc.

Metagenics, Inc. is a life sciences company and leading developer and manufacturer of science-based nutraceuticals medical foods, and therapeutic lifestyle change programs marketed to healthcare practitioners worldwide. It is headquartered inSan Clemente, Calif. with manufacturing and multiple research facilities located in Gig Harbor, Wash., including its MetaProteomics® Nutrigenomics Research Center and its Functional Medicine Research CenterSM for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. The company demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the NPA, NSF International, and TGA. For more information about Metagenics, please visit

About ImpediMed Limited

ImpediMed Limited develops and globally markets medical device systems for use in non-invasive screening and monitoring of fluid status and body composition. ImpediMed’s product range includes medical devices for body composition analysis and early detection and monitoring of secondary lymphoedema in cancer survivors. ImpediMed’s products are TGA and FDA cleared as well as CE marked for global distribution. For more information about ImpediMed, please visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.